Study of cryo-assisted radiofrequency ablation for early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new way to burn and remove lung tumors using a tool that goes through a bronchoscope (a thin tube passed through the mouth). It is done during a standard bronchoscopy and may help treat lung cancer while avoiding more invasive surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a single lung nodule that is 2.5 cm (about 1 inch) or smaller.
- You have a confirmed lung cancer diagnosis.
- You are able to have surgery to remove the nodule.
- The nodule is at least 2 cm away from major blood vessels, airways, or the lung lining.
- You are 18 years or older and have given your consent.
- You do not have serious bleeding problems, a cardiac implant (like a pacemaker), or are pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to freeze and destroy small lung tumors: through the chest wall or through the airways. It’s for people with early-stage lung cancer who are not able or willing to have surgery.
This study tests a new way to freeze and destroy small lung tumors using a thin tube with a camera (bronchoscope) to guide the freezing probe. It is for people with early-stage lung cancer or limited lung metastases who cannot or prefer not to have surgery or radiation.
This study tests a freezing technique, called cryoablation, to destroy small lung tumors. It may be an option if you cannot have surgery or other treatments, or if those treatments haven't worked.
This study tests a new approach for people with early-stage lung cancer that can be removed with surgery. Before surgery, patients receive a treatment called cryo-thermal ablation to freeze and heat the tumor, along with an immunotherapy drug (toripalimab) and chemotherapy. The goal is to see if this combination shrinks tumors and improves outcomes after surgery.
This trial tests a combination of an immunotherapy drug (sintilimab), chemotherapy, and a procedure called cryoablation (freezing the tumor) for people with a type of lung cancer called non-small cell lung cancer that has spread or come back. The goal is to see if this combination is safe and effective.
This trial tests a treatment that uses extreme cold (cryoablation) along with immunotherapy (tislelizumab) and chemotherapy before and after surgery for people with early-stage lung cancer that can be removed. The goal is to see if this combination helps prevent the cancer from coming back.
Hear when a new Cryotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.